4.0 Review

Diagnosis and Management of Conjunctivitis for the Dermatologist

期刊

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
卷 22, 期 2, 页码 200-206

出版社

SAGE PUBLICATIONS INC
DOI: 10.1177/1203475417743233

关键词

atopic dermatitis; conjunctivitis; dupilumab; interleukin-4; interleukin-13

向作者/读者索取更多资源

Atopic dermatitis is a chronic, sometimes relapsing inflammatory skin condition that presents with pruritus and characteristic skin manifestations. Conjunctivitis is a common ocular comorbidity affecting almost half of patients with the risk increasing with atopic dermatitis severity. Recent targeted biologic therapies that successfully treat atopic skin disease, including dupilumab, which blocks interleukin (IL)-4 and IL-13, as well as agents that block IL-13 alone, have been associated with an increased rate of conjunctivitis in clinical trials. Because conjunctivitis commonly occurs in patients with atopic dermatitis and as the treatment with targeted biologic agents may increase the risk or severity of conjunctivitis, it is important that dermatologists recognize symptoms, appreciate treatment options, and know when referral to an ophthalmologist is appropriate.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据